Manufacturer of the adrenocortical cancer treatment drug mitotane (mitotane)

Mitotane (Mitotane) is a drug used to treat adrenocortical cancer. Its manufacturer is Merck (Merck) of Germany. As a global multinational pharmaceutical company, Merck is committed to developing and producing high-quality medicines to meet the medical needs of patients around the world.

Merck & Co., founded in1668, is one of the oldest pharmaceutical companies in the world. Today, Merck has developed into a global pharmaceutical giant with an extensive product line and global market network. The company has extensive experience and expertise in medicine, life sciences and biopharmaceuticals and is committed to providing innovative medical solutions to patients around the world.

Mitotane , an important product of Merck, is a lipase inducer that inhibits the proliferation and spread of cancer cells by affecting the function of adrenocortical cells. As one of the first-line treatments for adrenocortical cancer, Mitotane plays an important role in Merck's production line.

Mitotane Although it has been marketed in China, it has been on the market for a short time and has not yet been included in the scope of medical insurance. Therefore, it is still difficult for patients to purchase this drug in domestic hospitals. For more information, ask your local hospital pharmacy. Abroad, Mitotane has two versions: original drug and generic version. The original drugs are mainly European versions, priced as high as more than 9,000 yuan. In comparison, generic drugs, especially the version produced in Laos, are more affordable at about more than 3,000 yuan, and their pharmaceutical ingredients are basically the same as the original drugs.

In general, Merck, as the manufacturer of mitotane , with its rich pharmaceutical experience, global market network and high-quality product quality, Merck provides an effective treatment option for patients with adrenocortical cancer and has made important contributions to the global medical and health industry.